Drug intelligence / Profile preview

S115

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

S115 is a novel heteroaromatic thiosemicarbazone compound that has demonstrated anticancer effects in both in vitro and in vivo studies. Its precise mechanism of action, beyond its classification as a thiosemicarbazone, is not detailed in the provided context, but compounds of this class are often explored for their ability to interfere with cellular processes critical for cancer cell proliferation and survival.

Beyond the preview

Go deeper on S115.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S115.

Explore the full profile